Investigational Product Disclaimer

The radiotracer discussed on this website is an investigational imaging agent and has not been approved by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), or any other regulatory authority for commercial distribution or clinical use.As the drug sponsor, PainVox provides this information solely for educational and scientific informational purposes to share findings from peer-reviewed clinical research papers. The safety and effectiveness of this compound have not been established by any regulatory body.This website does not offer medical advice, and the information provided should not be used to diagnose or treat any medical condition. This site does not host or facilitate enrollment for clinical trials. If you are a patient, please consult with a qualified healthcare provider to discuss your medical options.Forward-Looking StatementsThis website contains forward-looking statements regarding PainVox’s regulatory plans, including the anticipated submission of a commercial Investigational New Drug (IND) application. These statements are based on current management expectations and are subject to risks, uncertainties, and changes in regulatory requirements or clinical data that could cause actual outcomes to differ materially.